We are live on ! Find out more
LFG

Lazard Frères Gestion Portfolio holdings

AUM $5.77B
1-Year Est. Return 23.8%
This Fund
S&P 500
This Quarter Est. Return
-13.44%
1 Year Est. Return
+23.8%
3 Year Est. Return
+77.58%
5 Year Est. Return
+103.46%
10 Year Est. Return
–
AUM
$2.78B
AUM Growth
-$539M
Cap. Flow
-$139M
Cap. Flow %
-5.01%
Top 10 Hldgs %
51.46%
Holding
73
New
3
Increased
21
Reduced
35
Closed
8

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$8.92M
2
EL icon
Estee Lauder
EL
+$4.31M
3
MSFT icon
Microsoft
MSFT
+$3.77M
4
DIS icon
Walt Disney
DIS
+$2.78M
5
V icon
Visa
V
+$2.62M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$34.6M
2
CVS icon
CVS Health
CVS
+$26.4M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$14M
4
CVX icon
Chevron
CVX
+$13.9M
5
RTX icon
RTX Corp
RTX
+$11.5M

Sector Composition

Rank Sector Weight
1 Technology 20.8%
2 Healthcare 16.17%
3 Financials 12.7%
4 Industrials 11.94%
5 Communication Services 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CARR icon
51
Carrier Global
CARR
$44.7B
$994K 0.04%
27,785
-3,055
-10% -$120K
NEM icon
52
Newmont
NEM
$128B
$840K 0.03%
14,000
-4,000
-22% -$283K
KO icon
53
Coca-Cola
KO
$378B
$747K 0.03%
11,913
+1,468
+14% +$93.1K
B
54
Barrick Mining
B
$70B
$707K 0.03%
40,000
-500
-1% -$10.8K
JMIA
55
Jumia Technologies
JMIA
$957M
$441K 0.02%
72,900
– –
LLY icon
56
Eli Lilly
LLY
$1.01T
$429K 0.02%
1,331
+636
+92% +$191K
TSLA icon
57
Tesla
TSLA
$1.41T
$425K 0.02%
1,869
– –
PFE icon
58
Pfizer
PFE
$157B
$414K 0.01%
7,952
+1,702
+27% +$86.7K
SYK icon
59
Stryker
SYK
$109B
$397K 0.01%
2,000
– –
MA icon
60
Mastercard
MA
$497B
$316K 0.01%
+986
New +$340K
ABT icon
61
Abbott
ABT
$177B
$271K 0.01%
2,500
– –
NVDA icon
62
NVIDIA
NVDA
$5.17T
$259K 0.01%
16,810
+410
+3% +$7.74K
LOW icon
63
Lowe's Companies
LOW
$109B
$241K 0.01%
+1,374
New +$265K
XOM icon
64
ExxonMobil
XOM
$672B
$237K 0.01%
2,700
-1,036
-28% -$93.4K
SLB icon
65
SLB Ltd
SLB
$77.6B
$218K 0.01%
6,090
-4,975
-45% -$207K
CVS icon
66
CVS Health
CVS
$117B
– –
-277,997
Closed -$26.4M
INTC icon
67
Intel
INTC
$534B
– –
-4,298
Closed -$221K
META icon
68
Meta Platforms (Facebook)
META
$1.72T
– –
-1,200
Closed -$269K
NEE icon
69
NextEra Energy
NEE
$168B
– –
-2,407
Closed -$203K
NFLX icon
70
Netflix
NFLX
$318B
– –
-8,280
Closed -$315K
ORCL icon
71
Oracle
ORCL
$433B
– –
-2,400
Closed -$200K
QQQ icon
72
Invesco QQQ Trust
QQQ
$474B
– –
-575
Closed -$208K
UNH icon
73
UnitedHealth
UNH
$337B
– –
-6,532
Closed -$3.33M
1 2
3

Similar funds

CCM
Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
DWA
Douglass Winthrop Advisors New York $5.8B AUM 11.8% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $5.75B AUM 39.93% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $5.8B AUM 88.72% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $5.71B AUM 63.42% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Lazard Frères Gestion's Q2 2022 Portfolio in Review

As of Q2 2022, Lazard Frères Gestion held 73 positions worth $2.78B, down 16% from $3.32B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Lazard Frères Gestion withdrew a net $139M in Q2 2022, closing 8 positions and reducing 35 holdings. Its most notable exit was CVS Health, an estimated $26.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Lazard Frères Gestion opened a new position in Embecta worth $1.13M.

  • Lazard Frères Gestion's largest Q2 2022 buy was Embecta: 44,415 shares worth $1.13M.
  • Lazard Frères Gestion added most to Nike in Q2 2022, an estimated $8.92M increase.
  • Lazard Frères Gestion's biggest Q2 2022 reduction was Home Depot, cutting an estimated $34.6M.
  • Lazard Frères Gestion fully exited CVS Health in Q2 2022, selling an estimated $26.4M.
  • Lazard Frères Gestion's ten largest holdings make up 51% of its $2.78B portfolio in Q2 2022.
  • Lazard Frères Gestion opened 3 new positions and closed 8 in Q2 2022.
  • Lazard Frères Gestion's portfolio value fell 16% quarter-over-quarter to $2.78B.

Based on Lazard Frères Gestion's 13F filing for Q2 2022, filed 28 Jul 2022.